Brenda Libby Coleman

Array ( [id] => 10954600 [patent_doc_number] => 20140357622 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-04 [patent_title] => 'CRYSTALLINE FORMS OF SODIUM 4--2-METHOXYBENZOATE' [patent_app_type] => utility [patent_app_number] => 14/151524 [patent_app_country] => US [patent_app_date] => 2014-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 17891 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14151524 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11480376 [patent_doc_number] => 09586905 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-03-07 [patent_title] => 'Benzoazepine derivative and medical use thereof' [patent_app_type] => utility [patent_app_number] => 14/438920 [patent_app_country] => US [patent_app_date] => 2013-12-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27026 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14438920 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10621596 [patent_doc_number] => 09340533 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-05-17 [patent_title] => '1,4-benzothiazepine-1-oxide derivative and pharmaceutical composition utilizing the same' [patent_app_type] => utility [patent_app_number] => 14/140185 [patent_app_country] => US [patent_app_date] => 2013-12-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 8400 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14140185 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11450282 [patent_doc_number] => 09573914 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-02-21 [patent_title] => 'Process for preparing benzothiazepines from gamma-aminoalkylbenzenes' [patent_app_type] => utility [patent_app_number] => 14/138893 [patent_app_country] => US [patent_app_date] => 2013-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13879 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14138893 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9597729 [patent_doc_number] => 20140194411 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-07-10 [patent_title] => 'BENZAZEPINES AS SEROTONIN 5-HT2C RECEPTOR LIGANDS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/138866 [patent_app_country] => US [patent_app_date] => 2013-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32392 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14138866 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9417890 [patent_doc_number] => 20140102540 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-04-17 [patent_title] => 'DYE, PHOTOELECTRIC CONVERSION ELEMENT USING THE SAME, PHOTOELECTROCHEMICAL CELL, AND METHOD OF PRODUCING DYE' [patent_app_type] => utility [patent_app_number] => 14/136995 [patent_app_country] => US [patent_app_date] => 2013-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 57522 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14136995 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10110035 [patent_doc_number] => 09145439 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-09-29 [patent_title] => 'Process for the preparation of 6-alpha-fluoro pregnanes' [patent_app_type] => utility [patent_app_number] => 14/109552 [patent_app_country] => US [patent_app_date] => 2013-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1550 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14109552 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10642525 [patent_doc_number] => 09359381 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-06-07 [patent_title] => 'Tricyclic compounds for inhibiting the CFTR channel' [patent_app_type] => utility [patent_app_number] => 14/653084 [patent_app_country] => US [patent_app_date] => 2013-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 86310 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14653084 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11698709 [patent_doc_number] => 09688612 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-06-27 [patent_title] => 'Axially chiral N-(2-acylaryl)-2-[5,7-dihydro-6h-dibenzo[c,e]azepin-6-yl] acetamide compound and chirality interconversion method of a-amino acid using the same' [patent_app_type] => utility [patent_app_number] => 14/651857 [patent_app_country] => US [patent_app_date] => 2013-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 19 [patent_no_of_words] => 20035 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14651857 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9546770 [patent_doc_number] => 20140171417 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-06-19 [patent_title] => 'TRICYCLIC COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 14/109922 [patent_app_country] => US [patent_app_date] => 2013-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 86425 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14109922 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9570061 [patent_doc_number] => 20140187774 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-07-03 [patent_title] => 'METHODS FOR PREPARING PYRIMIDINE DERIVATIVES USEFUL AS PROTEIN KINASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 14/100952 [patent_app_country] => US [patent_app_date] => 2013-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28421 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14100952 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12305679 [patent_doc_number] => 09938258 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-04-10 [patent_title] => Substituted 2,3-dihydrobenzofuranyl compounds and uses thereof [patent_app_type] => utility [patent_app_number] => 14/647662 [patent_app_country] => US [patent_app_date] => 2013-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 71953 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14647662 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10587660 [patent_doc_number] => 09309260 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-04-12 [patent_title] => 'Inhibitors of hepatitis C virus' [patent_app_type] => utility [patent_app_number] => 14/083429 [patent_app_country] => US [patent_app_date] => 2013-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 62911 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14083429 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9932183 [patent_doc_number] => 20150080376 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-03-19 [patent_title] => 'NOVEL POLYMORPHIC FORMS OF ALCAFTADINE' [patent_app_type] => utility [patent_app_number] => 14/370801 [patent_app_country] => US [patent_app_date] => 2013-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 3062 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14370801 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11075663 [patent_doc_number] => 20160272627 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-22 [patent_title] => 'POLYMORPHIC FORMS OF SUVOROXANT' [patent_app_type] => utility [patent_app_number] => 14/442269 [patent_app_country] => US [patent_app_date] => 2013-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 12291 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14442269 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9777992 [patent_doc_number] => 08853198 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-10-07 [patent_title] => 'Agents for treating disorders involving modulation of ryanodine receptors' [patent_app_type] => utility [patent_app_number] => 14/076474 [patent_app_country] => US [patent_app_date] => 2013-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 16537 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14076474 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10628670 [patent_doc_number] => 09346816 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-05-24 [patent_title] => '6,7,8,9-tetrahydro-5H-1,4,7,10a-tetraaza-cyclohept[f]indene derivatives, pharmaceutical compositions containing these compounds, their use and processes for preparing them' [patent_app_type] => utility [patent_app_number] => 14/072324 [patent_app_country] => US [patent_app_date] => 2013-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43676 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14072324 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9538365 [patent_doc_number] => 20140163012 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-06-12 [patent_title] => 'PYRIDO-/AZEPINO-BENZOFURAN AND PYRIDO-/AZEPINO-BENZOTHIOPHENE MCH-1 ANTAGONISTS, METHODS OF MAKING, AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 14/068470 [patent_app_country] => US [patent_app_date] => 2013-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 98795 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14068470 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9307146 [patent_doc_number] => 20140045820 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-13 [patent_title] => '2,5,6,7-Tetrahydro-[1,4]oxazepin-3-ylamine or 2,3,6,7-tetrahydro-[1,4]oxazepin-5-ylamine compounds' [patent_app_type] => utility [patent_app_number] => 14/059910 [patent_app_country] => US [patent_app_date] => 2013-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 53361 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14059910 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11767821 [patent_doc_number] => 09376396 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-06-28 [patent_title] => 'Acylaminocycloalkyl compounds suitable for treating disorders that respond to modulation of dopamine D3 receptor' [patent_app_type] => utility [patent_app_number] => 14/051626 [patent_app_country] => US [patent_app_date] => 2013-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22685 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14051626 [rel_patent_id] =>[rel_patent_doc_number] =>)